Real-time enrollment status for this chronic lymphocytic leukemia clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 1:53 PM UTC
| NCT Number | NCT07277231 |
| Recruiting Status | Recruiting |
| Condition | Chronic Lymphocytic Leukemia |
| Phase | PHASE3 |
| Target Enrollment | 500 participants |
| Active Locations | 22 sites in the US |
| Sponsor | BeOne Medicines |
| Last Updated on CT.gov | September 28, 2026 (2 weeks ago) |
As of October 15, 2026: Clinical trial NCT07277231 is currently recruiting participants. This phase3 study for chronic lymphocytic leukemia is actively seeking new participants at 22 locations across the United States. The study is sponsored by BeOne Medicines. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07277231 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07277231 was last updated 2 weeks ago (September 28, 2026). HelloStudys verifies this status automatically.